Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2012
09/19/2012EP2500018A1 Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure
09/19/2012EP2498798A1 Compositions and methods for wound treatment
09/19/2012EP2498785A1 Use of synergistic combinations of an avermectin and an antineoplastic compounds for the treatment of hematological malignancies
09/19/2012EP2498773A2 Compositions for the treatment of chemoresistant leukaemia and/or of potentially chemoresistant leukaemia
09/19/2012EP2498759A2 Immediate release tablet formulations
09/19/2012EP1666481B1 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor
09/19/2012CN1607006B Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
09/19/2012CN102686720A Method for inducing differentiation of dental pulp cells into odontoblasts
09/19/2012CN102686208A Microcapsules comprising benzoyl peroxide and topical compositions comprising them
09/19/2012CN102676516A New use of microRNA 145
09/19/2012CN102675655A Water-soluble fullerene and preparation and application methods thereof
09/19/2012CN102671202A Modified chitosan drug carrying microsphere and method for preparing same
09/19/2012CN102671198A Compound medicine for reducing blood pressure and blood fat and preparation method thereof
09/19/2012CN102671197A Medical composite containing deoxidation phenylephrine
09/19/2012CN102671196A Combinations of therapeutic agents for treating cancer
09/19/2012CN102671195A Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nsaid
09/19/2012CN102671181A High purity lipopeptides, lipopeptide micelles and processes for preparing same
09/19/2012CN102670674A Geranium strictipes R. Knuth effective part extract as well as preparation method and drug application
09/19/2012CN102670629A Compositions and methods for combination antiviral therapy
09/19/2012CN102670518A Preparation method for insoluble spherical medical granules
09/19/2012CN102670505A Technique for preparing quantitative spray suction agent for treatment of respiratory diseases
09/19/2012CN102670483A Electrostatic spinning fiber membrane preparation for treating hyperlipidemia and preparation method thereof
09/19/2012CN101796039B Phenylacetic acid compound
09/19/2012CN101732298B Treating benign prostate hyperplasia with SARMS
09/19/2012CN101698103B Medicine composite for treating B type diabetes
09/19/2012CN101389352B Agent for treating or preventing digestive ulcer
09/18/2012US8268981 Plasmodium malariae and plasmodium ovale genes and uses thereof
09/18/2012US8268974 Taking unfolded globular protein denaturing and refolding; generating vaccine against viral capsid protein; targeting vaccine to toll-like receptor; treating cancer
09/18/2012US8268873 Inhibitors of IMPDH enzyme
09/18/2012US8268842 Fused ring 4-oxopyrimidine derivative
09/18/2012US8268837 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268826 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
09/18/2012US8268821 Methods and compositions
09/18/2012US8268785 Use of a Pde 5 inhibitor for treating and preventing hypopigmentary disorders
09/18/2012US8268774 Method for reducing pain
09/18/2012US8268555 Method for combined sequential agent delivery and electroporation for cell structures and use thereof
09/18/2012US8268343 Non-hormonal vaginal contraceptive
09/18/2012US8268326 Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
09/18/2012US8268322 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor
09/18/2012US8268308 Means for the diagnosis and therapy of CTCL
09/18/2012US8268306 Pesticidal and antiparasitic compositions
09/18/2012US8267982 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
09/18/2012CA2666764C Long-term enteral feed for maintenance
09/18/2012CA2580080C Methods for antibody library screening
09/18/2012CA2529742C Composition of a vegf antagonist and an anti-proliferative agent
09/18/2012CA2507002C Solid drug for oral use
09/18/2012CA2492855C Myocardial perfusion imaging using a2a receptor agonists
09/18/2012CA2492156C Tablet composition containing kampo medicinal extract and its manufacturing process
09/18/2012CA2462610C Specific binding agents of human angiopoietin-2
09/18/2012CA2461896C Injections for eye tissues containing drug bonded to polyethylene glycol
09/18/2012CA2410662C Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
09/18/2012CA2388733C Food supplement for increasing lean mass and strength
09/18/2012CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia
09/18/2012CA2273083C Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/18/2012CA2226013C Preparations and methods for the treatment of t cell mediated diseases
09/13/2012WO2012120284A1 Use of glycopyrrolate for treating tachycardia
09/13/2012WO2012103444A3 Immunogenic compositions and reagents for preparing
09/13/2012US20120232089 Method of treating an anxiety disorder
09/13/2012US20120232028 Bicyclic Compound, Production and Use Thereof
09/13/2012US20120231075 Abuse-resistant opioid dosage form
09/13/2012US20120231068 Virucidal properties of various forms of sophorolipids
09/13/2012US20120231003 Ox2 Receptor Homologs
09/13/2012US20120230940 Conditioned cell culture medium compositions and methods of use
09/13/2012CA2828640A1 Use of glycopyrrolate for treating tachycardia
09/12/2012EP2497785A2 Hyaluronic acid derivative and drug containing the same
09/12/2012EP2497770A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
09/12/2012EP2497467A1 Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
09/12/2012EP2497460A1 Methods of reducing microbial contamination
09/12/2012EP2497459A1 Methods of reducing microbial contamination
09/12/2012EP2496583A1 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
09/12/2012EP2496233A1 Nutritional supplements for relief of dry eye
09/12/2012CN102665760A Primary bile acid and secondary bile acid generation regulator
09/12/2012CN102665721A Use of polysaccharides for treating stress and anxiety
09/12/2012CN102665715A Compositions for treatment of cystic fibrosis and other chronic diseases
09/12/2012CN102665708A A combination for the treatment of osteoarthritis
09/12/2012CN102665705A New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
09/12/2012CN102665679A Combination therapy for copd
09/12/2012CN102665678A Combination therapy for copd
09/12/2012CN102660542A Cervical carcinoma diagnosis and treatment method based on micro RNA
09/12/2012CN102659944A IL-18 binding proteins
09/12/2012CN102657868A 5-hydroxy tryptamine 2 receptor antagonist or transporter inhibitor for treating fatty liver or hyperlipemia
09/12/2012CN102657867A Transcriptional regulator combination
09/12/2012CN102657664A Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
09/12/2012CN102657630A Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
09/12/2012CN102657598A Porous inorganic material based oral preparation of secondary-dispersion insoluble drug and preparation method thereof
09/12/2012CN102657597A Biodegradable super-molecular hydrogel loaded with antitumor medicament and preparation method thereof
09/12/2012CN102018959B Method and reagent for preventing and treating heart disease
09/12/2012CN101987197B Method and reagent for inhibiting invasiveness of cancer cells
09/12/2012CN101244039B Novel method for preparing indissoluble medicaments liposome preparations
09/12/2012CN101007851B Chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
09/11/2012US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
09/11/2012US8263559 Feline granulocyte macrophage colony stimulating factor proteins
09/11/2012US8263349 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
09/11/2012US8263346 Nonhuman model animal lacking the ability to control lymphocyte migration
09/11/2012US8263124 Anthistamine-decongestant pharmaceutical compositions
09/11/2012US8263121 Solid pharmaceutical preparation
09/11/2012US8263111 Non-hormonal vaginal contraceptive
09/11/2012US8263110 Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid mmatrix of a two biodegradable polymer matrix
09/11/2012US8263092 Alphavirus replicon particles as immunological adjuvants
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 1151